β-Catenin is essential for Müllerian duct regression during male sexual differentiation

Development

Volumn 138, Issue 10, 2011, Pages 1967-1975

  Kobayashi, Akio ^a,b,c   Allison Stewart, C ^b   Wang, Ying ^b   Fujioka, Kaoru ^c   Thomas, Nicholas C ^c   Jamin, Soazik P ^b,d   Behringer, Richard R ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d INSERM   (France)

Author keywords

Catenin; AMH; MIS; Mouse; M llerian duct regression; Wnt4

Indexed keywords

BETA CATENIN; MUELLERIAN INHIBITING FACTOR; WNT4 PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; MALE GENITAL SYSTEM; MESENCHYME; MOUSE; MUELLERIAN DUCT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-MULLERIAN HORMONE; BASE SEQUENCE; BETA CATENIN; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENITALIA, FEMALE; MALE; MESODERM; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MULLERIAN DUCTS; PREGNANCY; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; TESTIS; WNT PROTEINS;

EID: 79955565762     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.056143     Document Type: Article

References (62)

1. Allard, S., Adin, P., Gouedard, L., di Clemente, N., Josso, N., Orgebin-Crist, M. C., Picard, J. Y. and Xavier, F. (2000). Molecular mechanisms of hormonemediated Mullerian duct regression: involvement of beta-catenin. Development 127, 3349-3360.
2. Arango, N., Szotek, P., Manganaro, T., Oliva, E., Donahoe, P. and Teixeira, J. (2005). Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 288, 276-283.
3. Arango, N. A., Kobayashi, A., Wang, Y., Jamin, S. P., Lee, H. H., Orvis, G. D. and Behringer, R. R. (2008). A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice. Mol. Reprod. Dev. 75, 1154-1162.
4. Baarends, W. M., van Helmond, M. J., Post, M., van der Schoot, P. J., Hoogerbrugge, J. W., de Winter, J. P., Uilenbroek, J. T., Karels, B., Wilming, L. G., Meijers, J. H. et al. (1994). A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 120, 189-197.
5. Behringer, R. R., Cate, R. L., Froelick, G. J., Palmiter, R. D. and Brinster, R. L. (1990). Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature 345, 167-170.
6. Behringer, R. R., Finegold, M. J. and Cate, R. L. (1994). Mullerian-inhibiting substance function during mammalian sexual development. Cell 79, 415-425.
7. Belville, C., Josso, N. and Picard, J. Y. (1999). Persistence of Mullerian derivatives in males. Am. J. Med. Genet. 89, 218-223.
8. Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D. H., McMahon, A. P., Sommer, L., Boussadia, O. and Kemler, R. (2001). Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128, 1253-1264.
9. Chang, H., Gao, F., Guillou, F., Taketo, M. M., Huff, V. and Behringer, R. R. (2008). Wt1 negatively regulates beta-catenin signaling during testis development. Development 135, 1875-1885.
10. Chen, Y., Whetstone, H. C., Youn, A., Nadesan, P., Chow, E. C., Lin, A. C. and Alman, B. A. (2007). Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 282, 526-533.
11. Cox, S., Smith, L., Bogani, D., Cheeseman, M., Siggers, P. and Greenfield, A. (2006). Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Mullerian duct. Mol. Reprod. Dev. 73, 1008-1016.
12. DeFalco, T. and Capel, B. (2009). Gonad morphogenesis in vertebrates: divergent means to a convergent end. Annu. Rev. Cell Dev. Biol. 25, 457-482.
13. Deutscher, E. and Hung-Chang Yao, H. (2007). Essential roles of mesenchymederived beta-catenin in mouse Müllerian duct morphogenesis. Dev. Biol. 307, 227-236.
14. di Clemente, N., Wilson, C., Faure, E., Boussin, L., Carmillo, P., Tizard, R., Picard, J. Y., Vigier, B., Josso, N. and Cate, R. (1994). Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol. 8, 1006-1020.
15. di Clemente, N., Josso, N., Gouedard, L. and Belville, C. (2003). Components of the anti-Mullerian hormone signaling pathway in gonads. Mol. Cell. Endocrinol. 211, 9-14.
16. DiNapoli, L. and Capel, B. (2008). SRY and the standoff in sex determination. Mol. Endocrinol. 22, 1-9.
17. Farley, F. W., Soriano, P., Steffen, L. S. and Dymecki, S. M. (2000). Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28, 106-110.
18. Filali, M., Cheng, N., Abbott, D., Leontiev, V. and Engelhardt, J. F. (2002). Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem. 277, 33398-33410.
19. Guioli, S., Sekido, R. and Lovell-Badge, R. (2007). The origin of the Mullerian duct in chick and mouse. Dev. Biol. 302, 389-398.
20. Haegel, H., Larue, L., Ohsugi, M., Fedorov, L., Herrenknecht, K. and Kemler, R. (1995). Lack of beta-catenin affects mouse development at gastrulation. Development 121, 3529-3537.
21. Jamin, S. P., Arango, N. A., Mishina, Y., Hanks, M. C. and Behringer, R. R. (2002). Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet. 32, 408-410.
22. Josso, N., Picard, J. Y., Rey, R. and di Clemente, N. (2006). Testicular anti-Mullerian hormone: history, genetics, regulation and clinical applications. Pediatr. Endocrinol. Rev. 3, 347-358.
23. Kitisin, K., Saha, T., Blake, T., Golestaneh, N., Deng, M., Kim, C., Tang, Y., Shetty, K., Mishra, B. and Mishra, L. (2007). Tgf-Beta signaling in development. Sci. STKE 2007, cm1.
24. Kobayashi, A. and Behringer, R. (2003). Developmental genetics of the female reproductive tract in mammals. Nat. Rev. Genet. 4, 969-980.
25. Kobayashi, A., Shawlot, W., Kania, A. and Behringer, R. (2004). Requirement of Lim1 for female reproductive tract development. Development 131, 539-549.
26. Kobayashi, A., Kwan, K., Carroll, T., McMahon, A., Mendelsohn, C. and Behringer, R. (2005). Distinct and sequential tissue-specific activities of the LIMclass homeobox gene Lim1 for tubular morphogenesis during kidney development. Development 132, 2809-2823.
27. Kobayashi, A., Valerius, M. T., Mugford, J. W., Carroll, T. J., Self, M., Oliver, G. and McMahon, A. P. (2008). Six2 defines and regulates a multipotent selfrenewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3, 169-181.
28. Long, M. A. and Rossi, F. M. (2009). Silencing inhibits Cre-mediated recombination of the Z/AP and Z/EG reporters in adult cells. PLoS One 4, e5435.
29. Ma, L. (2009). Endocrine disruptors in female reproductive tract development and carcinogenesis. Trends Endocrinol. Metab. 20, 357-363.
30. Massague, J., Seoane, J. and Wotton, D. (2005). Smad transcription factors. Genes Dev. 19, 2783-2810.
31. Masse, J., Watrin, T., Laurent, A., Deschamps, S., Guerrier, D. and Pellerin, I. (2009). The developing female genital tract: from genetics to epigenetics. Int. J. Dev. Biol. 53, 411-424.
32. Mericskay, M., Kitajewski, J. and Sassoon, D. (2004). Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 131, 2061-2072.
33. Miller, C. and Sassoon, D. A. (1998). Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125, 3201-3211.
34. Mishina, Y., Rey, R., Finegold, M. J., Matzuk, M. M., Josso, N., Cate, R. L. and Behringer, R. R. (1996). Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10, 2577-2587.
35. Mishina, Y., Whitworth, D. J., Racine, C. and Behringer, R. R. (1999). High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140, 2084-2088.
36. Moustakas, A. and Heldin, C. H. (2009). The regulation of TGFbeta signal transduction. Development 136, 3699-3714.
37. Munsterberg, A. and Lovell-Badge, R. (1991). Expression of the mouse antimullerian hormone gene suggests a role in both male and female sexual differentiation. Development 113, 613-624.
38. Nef, S. and Parada, L. F. (2000). Hormones in male sexual development. Genes Dev. 14, 3075-3086.
39. Orvis, G. D. and Behringer, R. R. (2007). Cellular mechanisms of Mullerian duct formation in the mouse. Dev. Biol. 306, 493-504.
40. Orvis, G. D., Jamin, S. P., Kwan, K. M., Mishina, Y., Kaartinen, V. M., Huang, S., Roberts, A. B., Umans, L., Huylebroeck, D., Zwijsen, A. et al. (2008). Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol. Reprod. 78, 994-1001.
41. Park, J., Valerius, M. and McMahon, A. (2007). Wnt/{beta}-catenin signaling regulates nephron induction during mouse kidney development. Development 134, 2533-2539.
42. Parr, B. A. and McMahon, A. P. (1995). Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature 374, 350-353.
43. Parr, B. A. and McMahon, A. P. (1998). Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395, 707-710.
44. Perantoni, A., Timofeeva, O., Naillat, F., Richman, C., Pajni-Underwood, S., Wilson, C., Vainio, S., Dove, L. and Lewandoski, M. (2005). Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 132, 3859-3871.
45. Picon, R. (1969). Action of the fetal testis on the development in vitro of the Mullerian ducts in the rat (French). Arch. Anat. Microsc. Morphol. Exp. 58, 1-19.
46. Polanco, J. C. and Koopman, P. (2007). Sry and the hesitant beginnings of male development. Dev. Biol. 302, 13-24.
47. Roberts, L. M., Visser, J. A. and Ingraham, H. A. (2002). Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development 129, 1487-1496.
48. Sekido, R. and Lovell-Badge, R. (2009). Sex determination and SRY: down to a wink and a nudge? Trends Genet. 25, 19-29.
49. Shawlot, W. and Behringer, R. (1995). Requirement for Lim1 in head-organizer function. Nature 374, 425-430.
50. Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71.
51. Soshnikova, N., Zechner, D., Huelsken, J., Mishina, Y., Behringer, R. R., Taketo, M. M., Crenshaw, E. B., 3rd and Birchmeier, W. (2003). Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb. Genes Dev. 17, 1963-1968.
52. Stark, K., Vainio, S., Vassileva, G. and McMahon, A. P. (1994). Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372, 679-683.
53. Tallquist, M. D. and Soriano, P. (2000). Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26, 113-115.
54. Teixeira, J., Maheswaran, S. and Donahoe, P. K. (2001). Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr. Rev. 22, 657-674.
55. Tsuji, M., Shima, H., Yonemura, C. Y., Brody, J., Donahoe, P. K. and Cunha, G. R. (1992). Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat. Endocrinology 131, 1481-1488.
56. Vainio, S., Heikkila, M., Kispert, A., Chin, N. and McMahon, A. P. (1999). Female development in mammals is regulated by Wnt-4 signalling. Nature 397, 405-409.
57. van Amerongen, R. and Nusse, R. (2009). Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214.
58. Verheyen, E. M. and Gottardi, C. J. (2010). Regulation of Wnt/beta-catenin signaling by protein kinases. Dev. Dyn. 239, 34-44.
59. Wang, Y., Cheon, D. J., Lu, Z., Cunningham, S. L., Chen, C. M., Luo, R. Z., Xing, D., Orsulic, S., Bast, R. C., Jr and Behringer, R. R. (2008). MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse. Differentiation 76, 1081-1092.
60. Waters, P. D., Wallis, M. C. and Marshall Graves, J. A. (2007). Mammalian sex-Origin and evolution of the Y chromosome and SRY. Semin. Cell Dev. Biol. 18, 389-400.
61. Zhan, Y., Fujino, A., MacLaughlin, D. T., Manganaro, T. F., Szotek, P. P., Arango, N. A., Teixeira, J. and Donahoe, P. K. (2006). Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 133, 2359-2369.
62. Zhang, M., Yan, Y., Lim, Y. B., Tang, D., Xie, R., Chen, A., Tai, P., Harris, S. E., Xing, L., Qin, Y. X. et al. (2009). BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J. Cell. Biochem 108, 896-905.